about
Ethionamide activation and sensitivity in multidrug-resistant Mycobacterium tuberculosisAre survey-based estimates of the burden of drug resistant TB too low? Insight from a simulation studyPopulation health impact and cost-effectiveness of tuberculosis diagnosis with Xpert MTB/RIF: a dynamic simulation and economic evaluationA cross sectional study of knowledge and attitudes towards tuberculosis amongst front-line tuberculosis personnel in high burden areas of Lima, PeruAn ethA-ethR-deficient Mycobacterium bovis BCG mutant displays increased adherence to mammalian cells and greater persistence in vivo, which correlate with altered mycolic acid compositionFeasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation studyRapid molecular detection of tuberculosis and rifampin resistanceIdentification of new diamine scaffolds with activity against Mycobacterium tuberculosis.Genomic analysis of globally diverse Mycobacterium tuberculosis strains provides insights into the emergence and spread of multidrug resistance.Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technologyEpidemiology and treatment of multidrug resistant tuberculosisNovel trisubstituted benzimidazoles, targeting Mtb FtsZ, as a new class of antitubercular agents.Community based approaches to the control of multidrug resistant tuberculosis: introducing "DOTS-plus".Evaluation of Etest for susceptibility testing of Mycobacterium tuberculosis.Diagnostic delays and clinical decision making with centralized Xpert MTB/RIF testing in Durban, South Africa.A meta-analysis of drug resistant tuberculosis in Sub-Saharan Africa: how strongly associated with previous treatment and HIV co-infection?TSH-CHECK-1 test: diagnostic accuracy and potential application to initiating treatment for hypothyroidism in patients on anti-tuberculosis drugs.Multidrug-resistant tuberculosis in central AsiaIncreasing access to the MDR-TB surveillance programme through a collaborative model in western Kenya.Implementation validation performed in Rwanda to determine whether the INNO-LiPA Rif.TB line probe assay can be used for detection of multidrug-resistant Mycobacterium tuberculosis in low-resource countriesEvaluation of the speed-oligo direct Mycobacterium tuberculosis assay for molecular detection of mycobacteria in clinical respiratory specimens.Multicenter evaluation of genechip for detection of multidrug-resistant Mycobacterium tuberculosis.The transmission and control of XDR TB in South Africa: an operations research and mathematical modelling approach.The Incidence of Amikacin Ototoxicity in Multidrug-ResistantTuberculosis Patients.Double Standards in Global Health: Medicine, Human Rights Law and Multidrug-Resistant TB Treatment Policy.Recent advances in tuberculosis and nontuberculous mycobacteria lung disease.Resazurin microtiter assay plate: simple and inexpensive method for detection of drug resistance in Mycobacterium tuberculosis.Mycobacterium tuberculosis drug resistance, GhanaTo Test or Not to Test? Ending the Age-Old Debate for Drug-Resistant Tuberculosis.Evaluation of Xpert MTB/RIF assay for detection of Mycobacterium tuberculosis in stool samples of adults with pulmonary tuberculosis
P2860
Q28344564-DC3192E1-EA37-4C1B-B2A0-9E8F40E34DF4Q28472943-87591EAF-8775-4034-A685-5B07AC1DD6D6Q28485280-CF41F5C5-4CE4-4849-BDA4-4419880C49DAQ28533646-AC2CC82A-8225-4066-8612-6704980E3738Q28659734-1C92B40B-B496-4F1A-8A3D-46D8597E65D3Q29615717-7E89EEC8-B0F1-486F-B87E-A6F1F482DAC6Q29617127-0664636C-78C0-4AF6-B2F8-2DBB4A495CD5Q33244525-405607A8-1515-47B9-99A2-7EAE643D683AQ33595994-C78EE15A-0790-4F6B-8294-7FA1F09564F6Q33614228-C074987E-DB7B-4B32-BC04-D9946B75E07FQ33710690-3ABE739D-B05F-4D02-9A9E-7C6D275C7B4EQ33761632-C73BE498-FAC1-4AC7-9F33-E4D648197369Q33791822-3AA82149-89F6-415F-A231-0F89C0507E2EQ33970052-BE3172B9-3FAC-4404-AA80-D387375FFD33Q34340867-A2DA6110-C6AD-441E-ADB5-F3203E365E64Q35059462-AF7A7640-6B18-4523-9845-5190437C380EQ35839926-1DFFB344-BCCF-42EA-847C-D63675BC54E9Q35880603-3BE90265-8FF9-4BE6-99B0-64901BC76581Q36050648-6C76E707-1480-4EE1-807C-6E6F766A98ABQ36098632-F6C85C3D-41DD-437A-AAF6-8066DF3B4DB4Q36506321-A395240D-44C4-4D68-AA52-4EA73EF60E3BQ37026454-9D8D948F-553B-4BD8-B6B5-495C840766ACQ37208930-17C83ECF-1E4F-471B-A018-46C16139F959Q37268122-7D5E8586-3AA8-40AC-9D5F-C320AE06A853Q37351078-19BAF39F-96B8-445C-9F10-AE9813BC74CAQ38118312-45799B33-5372-4675-934C-7CAD82B2F712Q39335226-8D00DDDD-497E-4C90-976D-FBAEE216AE5DQ42618663-E869088A-1608-4F5A-96AA-BDCAF62EC1CAQ47852798-AA57E529-5DDC-4F8B-B48B-B1695B414B2AQ57927358-2E57FC8C-757B-437E-B683-E2D5BA3D9B75
P2860
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
The dilemma of MDR-TB in the global era.
@en
The dilemma of MDR-TB in the global era.
@nl
type
label
The dilemma of MDR-TB in the global era.
@en
The dilemma of MDR-TB in the global era.
@nl
prefLabel
The dilemma of MDR-TB in the global era.
@en
The dilemma of MDR-TB in the global era.
@nl
P2093
P1476
The dilemma of MDR-TB in the global era
@en
P2093
P304
P577
1998-11-01T00:00:00Z